Viewing Study NCT06338800



Ignite Creation Date: 2024-05-06 @ 8:19 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06338800
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-01
First Post: 2024-03-19

Brief Title: One Session Virtual Reality During Ongoing Treatment for Anxiety Feasibility in Children and Adolescents
Sponsor: Accare
Organization: Accare

Study Overview

Official Title: One Session Virtual Reality During Ongoing Treatment for Anxiety Feasibility in Children and Adolescents
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this study is to evaluate one session with exposure with Virtual Reality VR in in children and adolescents aged 8-18 years with an anxiety disorder The main questions it aims to answer are

1 What are the expectations of children and adolescents and therapists with VR exposure
2 What is the acceptability of the VR session positive and negative effects
3 What are possible working mechanisms of VR exposure During ongoing treatment participants will receive a session of exposure with VR
Detailed Description: Cognitive behavioral therapy is an effective treatment for anxiety disorders with exposure as the most important working ingredient Exposure therapy can be challenging to implement in face-to-face settings Virtual reality VR has emerged as a promising tool for delivering exposure therapy

In the current study the researchers will examine children and adolescents that will participate in a single session of VR exposure during their regular treatment n30 Willingness to participate in exposure in vivo will be assessed directly before and directly after the session During the session anxiety idiosyncratic expectations and self-efficacy will be assessed Expectations will be measured before the session and acceptability after the session

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None